The slowed gut motility that helps with weight loss also slows bowel movements
Lower doses (e.g., 0.5 mg weekly ) may suffice for some individuals to maintain results with fewer side effects
heart attack, stroke, death from heart disease) in adults with cardiovascular disease and either obesity or overweight Both Rybelsus and the Wegovy pill are indicated alongside diet and exercise, and manufactured by Novo Nordisk
Physicians and medical experts want to inform patients about what to expect while taking the drug
One small-scale trial was found to support the use of locally administered estriol in improving subjective outcomes
Where GLP-1 Receptors Are Located: Pancreas (insulin and glucagon regulation) Stomach (slowing emptying) Brain (appetite control) Heart (cardiovascular benefits) Liver (glucose production regulation) How Tirzepatide Works: Dual GIP and GLP-1 Receptor Activation: Tirzepatide activates two hormone receptors instead of one, creating a more comprehensive metabolic effect: GLP-1 Effects (Same as Semaglutide): Increased insulin secretion Decreased glucagon production Slowed gastric emptying Reduced appetite through brain signaling Enhanced satiety Additional GIP Effects: GIP (glucose-dependent insulinotropic polypeptide) adds complementary benefits: Enhanced Insulin Response: GIP amplifies insulin secretion even more than GLP-1 alone, particularly after meals when blood sugar is elevated